GlassScriptPhysician profile
Robert Edward Martin
NPI 1619978210
$852.95
in general payments reported to CMS, 2019-2025
11 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2021: $79.64 · 2022: $69.24 · 2023: $198 · 2024: $70.19 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $131.00 | 2019 | |
| Tactile Systems Technology INC | $119.60 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Pfizer INC. | $113.66 | 2019-2023 | |
| Cashflow Solutions, LLC | $103.57 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Boston Scientific Corporation | $90.89 | 2023-2025 | Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $66.65 | 2021-2022 | |
| Amgen INC. | $65.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $60.06 | 2019-2023 | Camzyos |
| Medtronic, INC. | $38.84 | 2024-2025 | Venaseal |
| Biocompatibles, INC. | $32.91 | 2019 | |
| Abiomed | $30.73 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.